InsidersTradesSigma
iBio, Inc.: directors' dealings · United States · SEC (Form 4)
SEC:ibio-inc-8e95f3US·SEC (Form 4)Mcap 72M€Healthcare
Explore the full management transaction log of iBio, Inc., a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Healthcare sector, iBio, Inc. has published 2 insider filings. Market capitalisation: €72.3m. The latest transaction was filed on 14 March 2022 · Cession. Among the most active insiders: Maddux Randy Joe. The full history is free.
2
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€30,229
2 ops.
Sell Volume
Financial data
FY ended June 2025 · cache
1.46 €
Analyst consensus
6 analystsStrong buy
4.20 €Target 5.53 €(+280%)7.00 €
Income statement
Revenue400 k€
Gross profit2.2 M€542% margin
Net income−18.4 M€-4594.3% margin
Valuation
PER (forward)-4.6x
P/Book0.6x
Balance sheet & cash
Market cap72.3 M€
Total debt3.5 M€
Free Cash Flow−15.3 M€
Debt / Equity3%
Profitability & ownership
ROE-62.1%
ROA-34.5%
% insiders1.7%
% institutions38.7%
Last declaration on 14 March 2022
Declarations2 total
Executives▼Sale28SEC
€22,54437,243 shares@ €0.60530.031% mcap100.0% of flow
Common Stock
SEC:0001104659-22-033319:0·
Executives▼Sale16SEC
€7,68524,625 shares@ €0.31210.011% mcap100.0% of flow
Common Stock
SEC:0001104659-22-033320:0·
2 of 2 declarations